FDA Issues form 483 to Contract Pharmaceuticals Limited Canada
Enforcement Report - Week of March 13, 2024
Contract Pharmacal`s Generic Famotidine Receives Approval in the U.S.
HAUPPAUGE, NY / ACCESSWIRE / June 23, 2023 / Contract Pharmacal Corp., (CPC), a leading contract development and manufacturing organization (CDMO) for the nutraceutical and pharmaceutical industries, is pleased to welcome Larry Lapila to the team as Vice President of Business Development. Lapila has decades of experience as a seasoned executive in the pharmaceutical industry and has spent his entire career building sales and driving growth and profitability of organizations. Most recently, Lapila served as President of Breckenridge Pharmaceutical and Florida Pharmaceutical Products, LLC.
Contract Pharmacal Corp. Wins CVS’s 2022 Leading With Heart Award
Contract Pharmacal Corp. Welcomes Glenn Langberg as Chief Strategy Officer
Enforcement Report - Week of February 19, 2020